Publication: Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei
1
Issued Date
2005-06-01
Resource Type
ISSN
03057453
Other identifier(s)
2-s2.0-21244477888
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Antimicrobial Chemotherapy. Vol.55, No.6 (2005), 1029-1031
Suggested Citation
Vanaporn Wuthiekanun, Allen C. Cheng, Wirongrong Chierakul, Premjit Amornchai, Direk Limmathurotsakul, Wipada Chaowagul, Andrew J.H. Simpson, Jennifer M. Short, Gumphol Wongsuvan, Bina Maharjan, Nicholas J. White, Sharon J. Peacock Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei. Journal of Antimicrobial Chemotherapy. Vol.55, No.6 (2005), 1029-1031. doi:10.1093/jac/dki151 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/16968
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei
Abstract
Objectives: Trimethoprim/sulfamethoxazole is commonly used to treat melioidosis. Antimicrobial susceptibility testing using the disc diffusion method is commonly used in melioidosis-endemic areas, but may overestimate resistance to trimethoprim/sulfamethoxazole. Patients and methods: We performed disc diffusion and Etest on isolates from the first positive culture for all patients presenting to Sappasithiprasong Hospital, Ubon Ratchathani, Thailand, with culture-confirmed melioidosis between 1992 and 2003. Results: The estimated resistance rate for 1976 clinical Burkholderia pseudomallei isolates was 13% by Etest and 71% by disc diffusion. All isolates classed as either susceptible (n=358) or as having intermediate resistance (n=218) on disc diffusion were susceptible by Etest. Only 258 of the 1400 (18%) isolates classed as resistant on disc diffusion were resistant by Etest. Conclusions: Disc diffusion testing of B. pseudomallei may be useful as a limited screening tool in resource poor settings. Isolates assigned as 'susceptible' or 'intermediate' by disc diffusion may be viewed as 'susceptible'; those assigned as 'resistant' require further evaluation by MIC methodology. © The Author 2005. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved.